Phoenix Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$97.3M Buy
1,550,372
+1,485,404
+2,286% +$119M 0.92% 29
2025
Q4
$6.19M Sell
64,968
-11,340
-15% -$1.11M 0.07% 118
2025
Q3
$7.45M Sell
76,308
-36,970
-33% -$3.83M 0.09% 96
2025
Q2
$12.2M Buy
113,278
+7,371
+7% +$746K 0.16% 74
2025
Q1
$10.7M Sell
105,907
-28,112
-21% -$2.83M 0.16% 91
2024
Q4
$12M Sell
134,019
-45,033
-25% -$3.96M 0.16% 84
2024
Q3
$15M Buy
179,052
+54,439
+44% +$4.29M 0.22% 73
2024
Q2
$9.6M Sell
124,613
-19,647
-14% -$1.44M 0.15% 85
2024
Q1
$9.88M Buy
144,260
+16,423
+13% +$1.06M 0.14% 80
2023
Q4
$8.27M Sell
127,837
-6,252
-5% -$334K 0.14% 77
2023
Q3
$7.09M Sell
134,089
-10,268
-7% -$539K 0.13% 82
2023
Q2
$7.79M Buy
144,357
+38,884
+37% +$2.03M 0.16% 67
2023
Q1
$5.27M Buy
105,473
+37,787
+56% +$1.78M 0.12% 85
2022
Q4
$3.13M Buy
67,686
+17,926
+36% +$776K 0.06% 107
2022
Q3
$1.96M Sell
49,760
-2,699
-5% -$108K 0.04% 151
2022
Q2
$1.96M Sell
52,459
-9,794
-16% -$399K 0.04% 168
2022
Q1
$2.76M Buy
62,253
+51,524
+480% +$2.23M 0.05% 170
2021
Q4
$460K Sell
10,729
-2,299
-18% -$96.6K 0.01% 294
2021
Q3
$570K Sell
13,028
-228
-2% -$10.1K 0.01% 311
2021
Q2
$572K Sell
13,256
-423
-3% -$17.8K 0.01% 271
2021
Q1
$533K Sell
13,679
-3,749
-22% -$142K 0.01% 308
2020
Q4
$617K Buy
17,428
+9,025
+107% +$325K 0.02% 247
2020
Q3
$299K Buy
+8,403
New +$324K 0.01% 261

Other funds holding BSX

Phoenix Financial's BSX Position: Q1 2026 in Review

Phoenix Financial increased its Boston Scientific (BSX) stake by 2,286% in Q1 2026, buying an estimated $119M and bringing the position to 1,550,372 shares worth $97.3M. The position accounts for 0.92% of the portfolio, ranked #29.

Phoenix Financial first reported a position in BSX in Q3 2020 and has held it in 23 quarters since. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Phoenix Financial held 1,550,372 shares of Boston Scientific worth $97.3M as of Q1 2026.
  • Phoenix Financial bought 1,485,404 Boston Scientific shares in Q1 2026, an estimated $119M.
  • Boston Scientific made up 0.92% of Phoenix Financial's portfolio in Q1 2026, its #29 holding.
  • Phoenix Financial first reported a position in Boston Scientific in Q3 2020 and has held it in 23 quarters since.
  • 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Phoenix Financial's 13F filing for Q1 2026, filed 11 May 2026.